Kiniksa Pharmaceuticals Ltd. (KNSA) Financial Statements (2024 and earlier)

Company Profile

Business Address 23 OLD BOND STREET, FLOOR 3
LONDON, WIS 4PZ
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments206,371190,608182,201323,482233,380307,304
Cash and cash equivalents107,954122,715122,470114,03846,92871,976
Short-term investments98,41767,89359,731209,444186,452235,328
Restricted cash and investments    210  
Receivables21,26612,6603,985   
Inventory, net of allowances, customer advances and progress billings31,12221,5993,675   
Inventory31,12221,5993,675   
Contract with customer, asset, after allowance for credit loss  7,656    
Other undisclosed current assets17,53810,5376,5859,5578,2476,446
Total current assets:276,297243,060196,446333,249241,627313,750
Noncurrent Assets
Operating lease, right-of-use asset11,9315,3855,5506,5661,927
Property, plant and equipment7341,6582,8344,0516,3986,356
Intangible assets, net (including goodwill)17,25018,25019,250   
Intangible assets, net (excluding goodwill)17,25018,25019,250   
Restricted cash and investments     210210
Deferred costs      433
Deferred income tax assets219,283185,495 104,372
Other noncurrent assets8275,8248,7205,588  
Deferred tax assets, net1,216
Total noncurrent assets:250,025216,61236,35416,21512,9078,215
TOTAL ASSETS:526,322459,672232,800349,464254,534321,965
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities52,91338,01139,89929,70226,10827,336
Accounts payable8,2467,8991,8685035,69310,918
Accrued liabilities44,66730,11238,03129,19920,41516,418
Deferred revenue307    
Debt     1,697 
Other liabilities8,1935,7541,5443725218
Other undisclosed current liabilities2,2533,3013,3812,107 15,000
Total current liabilities:63,66647,06644,82431,84627,83042,554
Noncurrent Liabilities
Long-term debt and lease obligation:   2,6694,878955 
Liabilities, other than long-term debt23,81716,457270805326144
Accounts payable and accrued liabilities      144
Deferred revenue11,95412,000   
Other liabilities1,8581,839270805326 
Operating lease, liability10,0052,6182,6694,878955
Total noncurrent liabilities:23,81716,4572,9395,6831,281144
Total liabilities:87,48363,52347,76337,52929,11142,698
Equity
Equity, attributable to parent, including:438,839396,149185,037311,935225,423279,267
Additional paid in capital916,763888,120860,482829,424581,467473,483
Accumulated other comprehensive income (loss)644(66)(34)33(4)
Accumulated deficit(477,950)(492,034)(675,397)(517,473)(356,092)(194,225)
Other undisclosed equity, attributable to parent201918181513
Total equity:438,839396,149185,037311,935225,423279,267
TOTAL LIABILITIES AND EQUITY:526,322459,672232,800349,464254,534321,965

Income Statement (P&L) ($ in thousands)

6/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues270,259220,18038,544   
Cost of revenue
(Cost of Goods and Services Sold)
  (9,100)   
Other undisclosed gross profit      
Gross profit:270,259220,18029,444   
Operating expenses(205,524)(163,441)(186,080)(157,363)(169,963)(108,160)
Other undisclosed operating loss(89,931)(46,966)    
Operating income (loss):(25,196)9,773(156,636)(157,363)(169,963)(108,160)
Nonoperating income8,5441,253971,1346,0494,719
Investment income, nonoperating   971,1346,0494,719
Other nonoperating income8,5441,253    
Income (loss) from continuing operations before income taxes:(16,652)11,026(156,539)(156,229)(163,914)(103,441)
Income tax expense (benefit)30,736172,337(1,385)(5,152)2,047214
Income (loss) from continuing operations:14,084183,363(157,924)(161,381)(161,867)(103,227)
Loss before gain (loss) on sale of properties:(157,924)(161,381)(161,867)(103,227)
Net income (loss) available to common stockholders, diluted:14,084183,363(157,924)(161,381)(161,867)(103,227)

Comprehensive Income ($ in thousands)

6/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net income (loss):14,084183,363(157,924)(161,381)(161,867)(103,227)
Comprehensive income (loss):14,084183,363(157,924)(161,381)(161,867)(103,227)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(38)110(32)(67)37(4)
Comprehensive income (loss), net of tax, attributable to parent:14,046183,473(157,956)(161,448)(161,830)(103,231)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: